This approach may lead to better understanding of risk-mitigation strategies, and perhaps better outcomes in patients with secondary AML.
Risk stratification is leading to increasing numbers of new molecular targets in multiple myeloma.
Therapy with CAR T cells may benefit patients with highly refractory multiple myeloma, said U Penn’s Adam Cohen at ASCO 2018.
The use of geriatric assessment in routine care of older patients with advanced cancer may significantly improve doctor-patient communication.
A California study showed women are significantly undertreated for head and neck cancer, with several factors possibly accounting for the disparity.
In a CYCORE trial, mobile technology improved patient tracking, enabling clinicians to detect concerning symptoms early and respond quicker.
Salvage cryoablation following local recurrence post radiation may be a safe way to avoid or delay initiation of hormone deprivation therapy.
The approval should have a profound impact on patients with the rare tumor, according to experts.
A new analysis of PROSPER, presented at AUA 2018, suggests enzalutamide plus ADT may be superior to ADT alone in nonmetastatic CRPC.
A study led by Dr. Jun Mao of MSKCC found CBT and acupuncture each yielded clinically meaningful and durable sleep-related QOL improvements.